Together, our findings demonstrate that IL4I1+ TAMs and TDO2+ myCAFs synergistically establish an immunosuppressive, ferroptosis-resistant niche via AhR signaling in solid predominant LUAD and offer promising therapeutic strategies to reprogram the tumor microenvironment. The gene discussed is AHR; the disease is neoplasm.